Study Evaluating ECG Effects, Safety, Tolerability and Pharmacokinetics of Single Doses of Modufolin (Arfolitixorin) in Healthy Volunteers Tetrahydrofolate in Healthy Male Volunteers

NCT03203564 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Phase I Study in Healthy Volunteers to Evaluate ECG Effect

Interventions

DRUG: Modufolin (arfolitixorin)

Sponsor

Isofol Medical AB